If you received an MRI using gadolinium-based contrast agents even though you have kidney disease or decreased renal function, you were put at risk for the deadly dangerous complication known as Nephrogenic Systemic Fibrosis (NSF), also known as Nephrogenic Fibrosing Dermopathy (NFD). Once NSF develops, you may be facing:

• Expensive long-term care
• Permanent disability
• Death

 

You deserve compensation for your injuries. Compensation to pay your expenses. Compensation to make up for future lost income. Compensation to try and put your life back on track and prepare for the long-term consequences of this incurable illness.

 

To improve your chances of receiving the compensation you deserve, work with attorneys whose expertise in pharmaceutical injury litigation is recognized nationwide. The attorneys at Schlichter, Bogard & Denton have received that recognition. We have been appointed to the Gadolinium Plaintiffs' Steering Committee (PSC), the small group of attorneys leading gadolinium injury litigation nationwide. To learn what we may be able to do for you, schedule a free, no-obligation NSF consultation today.

 

Types of Compensation You May Receive for Gadolinium Exposure

 

If you suffered NSF as a result of exposure to gadolinium-based contrast agents, you may be eligible for compensation for:

• Actual and expected medical expenses
• Mobility and life aids in the event of disability
• Diminished earning capacity
• Pain and suffering

 

The level of your compensation depends on the circumstances in your case, but the attorneys at Schlichter, Bogard & Denton will work to ensure you receive the maximum compensation possible.

 

Gadolinium Malpractice

 

In response to the association between NSF and the use of gadolinium-based contrast agents, the FDA recommended specific protocols that should be followed by doctors in using these potentially dangerous pharmaceuticals. These procedures included:

• Screen patients for renal dysfunction prior to gadolinium-based contrast agent use
• Follow specific dosing instructions for the agent being used
• Allowing sufficient time for a dose to clear before giving a second dose
• Use gadolinium-based contrast agents for patients with renal dysfunction only if there is no other way to obtain essential diagnostic information
• For hemodialysis patients, use hemodialysis promptly following gadolinium exposure to increase elimination rate

 

If you doctor or other health care provider failed to follow any of these guidelines, they may be liable for medical malpractice. We can handle your malpractice lawsuit as well.

 

Prompt Action Necessary for Gadolinium Exposure

 

Lawsuits for gadolinium injuries are currently going forward. We at Schlichter, Bogard & Denton have obtained millions of dollars for persons with pharmaceutical injuries, and we are prepared to stand up for your rights. If you are facing the consequences of NSF, prompt action may be necessary to ensure you receive the compensation you deserve.

 

Please do not hesitate to schedule a no-obligation gadolinium injury consultation today.